| PEMOF29 | Increased frequency of experiencing multiple forms of discrimination in healthcare settings during the COVID-19 pandemic among African, Caribbean, and Black (ACB) people across Canada | Poster exhibition | Discrimination and key populations |
| EPC046 | In-country migration as a predictor of HIV infection among travestis and transgender women in Northeast Brazil | E-poster | Epidemiology of HIV in key populations (e.g., gay men and other men who have sex with men, sex workers, transgender people, people who inject rugs and prisoners and other incarcerated people)) |
| EPD413 | Incorporating social determinants of health into the mathematical modeling of HIV/AIDS | E-poster | Socioeconomic differences: Poverty, wealth and income inequalities |
| EPB126 | Incidental anaemia in patients started on antiretroviral therapy in Harare, Zimbabwe: a retrospective cohort study | E-poster | Other ART complications and adverse reactions |
| OALBB0105 | Incident tuberculosis as a risk factor for viral non-suppression 48 weeks among patients switched to dolutegravir based therapy with recycled nucleoside reverse transcriptase inhibitors in Lusaka, Zambia | Oral abstract session with live Q&A | Viral load and CD4 monitoring |
| EPC077 | Incidence of sexually transmitted infections among adolescent's men who have sex with men and transgender women enrolled in a PrEP cohort study in Brazil | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| EPC115 | Incidence of HIV infection and its burden of transmission among populations: a case study of Jos, North-Central Nigeria | E-poster | Determining the incidence of HIV |
| EPC201 | Incidence of HIV infection after initiation of Australian government-subsidisedpre-exposure prophylaxis (PrEP): a national whole-of-population cohort study using dispensing data | E-poster | Scale up of PrEP |
| PESAC12 | Incidence of HCV reinfection among people with HIV prior to and during periods of limited and broad access to direct-acting antiviral therapies for HCV in five countries | Poster exhibition | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| EPB108 | Incidence of cardiometabolic outcomes among people living with HIV initiated on INSTI versus non-INSTI antiretroviral therapies | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |